Please login to the form below
PMEA 2021 has officially launched – with a new online entry system
New ‘Response to the COVID-19 Pandemic Crisis’ category introduced for this year’s awards
New date announced for Communiqué Awards 2021!
The awards will now take place on 1 September 2021 at what is hoped will be a live event
AstraZeneca takes home Company of the Year award at PMEA 2020
The Company of the Year award recognises outstanding customer-centric achievement
Accord Healthcare’s COVID-19 agility praised at PMEA 2020
Accord Healthcare picks up inaugural Agility Award in Pharma Market Excellence
Sanofi Genzyme takes home New Product Introductions Award at PMEA 2020
Winning entry stood out in a strong category
COVID-19 Updates and Daily News
Featured jobs
- Home Working Medical Copy Writer & Senior Medical Copy Write...
-
Highly Competitive Salary, Bonus &Benefits
- Principal/ Senior/ Medical Writer – Global Med Ed and Comms Agen...
-
Highly competitive salary
- Senior Account Director & Associate Director - Healthcare Ad...
-
Highly Competitive Salary, Bonus &Benefits
-
Digital project manager
-
Competitive
-
Digital strategist
-
Competitive
- Account Manager - Healthcare Consultancy
-
Salary depending on experience
- FREELANCE Medical Writer, Senior Medical Writer, Principal Medic...
-
Highly Competitive Day Rate, Bonus &Benefits
-
Digital account director
-
Competitive
- Client Services Director +, Remote or London – Leadership Opport...
-
Highly Competitive Salary, Bonus &Benefits
- FREELANCE (Outside IR35) Opportunities for this week below!!!
-
Superb Day Rate
- Editor & Senior Editor - Medical Communications - Home Based
-
Highly Competitive Salary, Bonus &Benefits
- Israel study suggests Pfizer/BioNTech vaccine is less effective against Delta variant
- Bayer’s BlueRock Therapeutics gains FDA fast track for Parkinson’s disease cell therapy
- GSK reveals plans for £400m R&D facility expansion in England
- FDA advisory committee votes against approval of AZ, FibroGen's roxadustat
- Novartis highlights potential of its radioligand therapy in prostate cancer at ASCO
- Novavax announces further delays for regulatory filings of COVID-19 vaccine
- Pfizer and Arvinas announce $1bn deal for investigational oral protein degrader
- Roche engaged in talks with FDA for Alzheimer’s drug candidate
- One dose of AZ’s COVID-19 vaccine ‘highly effective’ against severe disease from variants
- The future of work has been just around the corner for some time...
- Investigating the Complexities of the Canadian & Global Health Systems
- Impetus Digital Overview
- Amgen signs $180m nanotechnology cancer deal
- British officials reportedly monitoring Philip Morris’ proposed acquisition of Vectura
- Roche engaged in talks with FDA for Alzheimer’s drug candidate
- AZ’s comeback drug cediranib stumbles in phase 3 trial
- Israel study suggests Pfizer/BioNTech vaccine is less effective against Delta variant
- MHRA outlines two-year delivery plan with ‘patient first’ focus
PMHub
EPG Health
REACH, ENGAGE & MEASURE HCPs ONLINE - Accomplish meaningful engagement via Medthority (www.medthority.com), a trusted independent medical website. Support the...
Latest intelligence
- The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
- Chris Ross conducts a literary-inspired review of pharma’s pursuit of communications excellence...
- The key to psoriasis innovation? Dispelling the shadow of the JAK inhibitor
- Powerful therapies that can improve skin clarity dominate the psoriasis landscape, so why are most patients stuck in a cycle of ineffective topicals? Fishawack Health explores the market and reveals...
- Virtual Speaker Program: A Customer Story
- Learn how we helped our client develop a virtual speaker program and roll out a series of regional peer-to-peer education sessions....
